Ignite Creation Date:
2025-12-24 @ 8:01 PM
Ignite Modification Date:
2025-12-29 @ 2:34 AM
Study NCT ID:
NCT05127304
Status:
COMPLETED
Last Update Posted:
2023-11-13
First Post:
2021-11-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Using US Medical and Pharmacy Claim Records to Compare the Resource Use, Cost, and Outcomes of People With COPD Who Take Either Tiotropium + Olodaterol or Fluticasone + Umeclidinium + Vilanterol
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-26
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-03
Completion Date Type:
ACTUAL
First Submit Date:
2021-11-12
First Submit QC Date:
None
Study First Post Date:
2021-11-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-01-30
Results First Submit QC Date:
None
Results First Post Date:
2023-11-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-30
Last Update Post Date:
2023-11-13
Last Update Post Date Type:
ACTUAL